As the life sciences industry moves towards serialization under U.S. DSCSA and EU FMD requirements, both pharmaceutical companies and CMOs are negotiating multiple relationships. If companies don’t work together, there is big risk for both sides. Watch this two-minute video to learn what to do – and not do – to achieve readiness with your partners.
